Exclusive articles:
Bright Minds Targets Epilepsy with Breakthrough 5-HT2C Agonist
Bright Minds Biosciences launches a Phase 2 trial for BMB-101, targeting drug-resistant epilepsy with high unmet needs.
The company trades at a $5M market cap,...
Everything You Need to Know About the Stock Markets on 9/11
Asian markets face volatility due to rising oil prices and economic uncertainties, affecting key indices like Japan’s Nikkei and China’s Shanghai Composite.
Apple’s €13 billion...
Premier American Uranium is Advancing U.S. Uranium Projects for Future Growth
Premier holds significant uranium assets in New Mexico, Wyoming, and Colorado, positioning itself as a key player in the U.S. uranium market.
Positive drilling updates...
Li-FT Power Expands Horizons in Canada’s Lithium Market
Li-FT Power continues to grow its portfolio, recently acquiring 9,681 hectares at the Cali Project and the Shorty West Lithium claim to strengthen its...
Greenridge’s Bold Move to Become a Powerhouse in Uranium Exploration
Greenridge's acquisition of ALX Resources positions it as a top uranium explorer with over 276,000 hectares of prime assets.
The combined company diversifies into uranium,...
